1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsRare Neurodegenerative Disease Grants Program (OOPD) is sponsored by Food and Drug Administration (FDA), Office of Orphan Products Development (OOPD). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
FDA Rare Neurodegenerative Disease Grants Program | FDA Skip to in this section menu Medical Products for Rare Diseases and Conditions Grant Programs to Support Development of Medical Products for Rare Diseases FDA Rare Neurodegenerative Disease Grants Program Grant Programs to Support Development of Medical Products for Rare Diseases Launched when the Accelerating Access to Critical Therapies for ALS (also referred to as ACT for ALS) law was enacted in December 2021, the Rare Neurodegenerative Disease (RNDD) grants program supports research in amyotrophic lateral sclerosis (ALS) and other rare neurodegenerative diseases in adults and children.
Under this program, FDA awards grants and contracts to public and private entities to cover costs of research and development of medical products intended to prevent, diagnose, mitigate, treat or cure ALS and other rare neurodegenerative diseases in adults and children. This program supports research in ALS as well as other rare neurodegenerative diseases. What are neurodegenerative diseases?
Neurodegenerative diseases occur when nerve cells in the brain or peripheral nervous system lose function over time and ultimately die. In general, they are incurable and debilitating conditions and are progressive. The term “rare disease or condition” is defined in 21 U.S.C.
360ee and generally they are considered by FDA as diseases with a prevalence of fewer than 200,000 people in the United States or in the case of an acute disease (e.g., less than one year duration), an annual incidence of fewer than 200,000 per year.
Some examples of what FDA currently considers rare neurodegenerative diseases include ALS, Cockayne syndrome, ataxia telangiectasia, mucopolysaccharidosis (MPS) type III, familial dysautonomia, and Niemann-Pick Type C.
To learn more about what qualifies for the RNDD grants program, please see: FDA Operational Definition of a Rare Neurodegenerative Disease Grants Awarded and Future Opportunities A list of grants awarded under this program is available at: Rare Neurodegenerative Disease Grants Awarded .
OOPD also administers the Orphan Products Grants Program , which fosters development of new medical products for rare diseases and conditions through clinical trials and natural history studies . Contact the OOPD grants team .
According to the current listing, eligibility includes: Researchers and organizations involved in the research and development of interventions for rare neurodegenerative diseases. Confirm the full requirements in the official notice before applying.
Rare Neurodegenerative Disease Grants Program (OOPD) is funded by Food and Drug Administration (FDA), Office of Orphan Products Development (OOPD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The AFID Infrastructure Grant program closes October 30, 2026. Awards top out at $50,000, they are reimbursable, and only a political subdivision can apply. The August round put $507,000 into 14 projects at an average of about $36,000.
Read articleThe Cold Chain Grants for Emergency Food Assistance Program closes October 1, 2026, funding cold storage equipment at up to $200,000 per project with a 10% cash match. But USDA is not awarding to food banks — it is awarding to nonprofit intermediaries who will run competitive subaward programs. Two audiences, two entirely different jobs, and one of them has 43 days.
Read articleMissouri's Department of Agriculture has reopened its Urban Agriculture Cost-Share Grant — reimbursing 75% of project costs up to $10,000, with applications due September 15, 2026. A companion Food Insecure Cost-Share Grant closes August 26. Here is how these small, fast state grants work, who qualifies under the Census 'urban area' definition, and how to layer them with the federal USDA Urban Agriculture and Innovative Production program for a durable urban-farming funding strategy.
Read article